-+ 0.00%
-+ 0.00%
-+ 0.00%

Baird Downgrades HCA Healthcare to Neutral, Lowers Price Target to $336

Benzinga·04/15/2025 11:35:02
Listen to the news
Baird analyst Michael Ha downgrades HCA Healthcare (NYSE:HCA) from Outperform to Neutral and lowers the price target from $396 to $336.